BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2851301)

  • 1. Receptor binding properties of the new calcium antagonist benidipine hydrochloride.
    Ishii A; Nishida K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1677-80. PubMed ID: 2851301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
    Ishii A; Nishida K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
    Ishii A
    Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes.
    Ishii A; Toyama J
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):191-6. PubMed ID: 7679151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive radioreceptor assay of the calcium antagonist benidipine hydrochloride in plasma and urine.
    Ishii A; Nishida K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1733-7. PubMed ID: 3219150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the calcium antagonist benidipine hydrochloride in plasma by sensitive radioimmunoassay.
    Akinaga S; Kobayashi H; Kobayashi S; Inoue A; Nakamizo N; Oka T
    Arzneimittelforschung; 1988 Nov; 38(11A):1738-41. PubMed ID: 3219151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1722-30. PubMed ID: 3219148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P; Ferry D; Lübbecke F; Glossman H
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs.
    Karasawa A; Ikeda J; Yamada K; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1695-7. PubMed ID: 3219142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
    Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
    Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatographic method for the quantification of the new calcium antagonist benidipine hydrochloride in plasma using electron capture detection.
    Kobayashi H; Kobayashi S; Inoue A; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1730-3. PubMed ID: 3219149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester.
    Muto K; Kuroda T; Kawato H; Karasawa A; Kubo K; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1662-5. PubMed ID: 3219137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of expected metabolites of benidipine hydrochloride.
    Muto K; Kuroda T; Kawato H; Nishikawa H; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1666-70. PubMed ID: 3219138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1702-7. PubMed ID: 3219144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.